Wang H, Naghavi M, Allen C, Barber RM, Carter A, Casey DC, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459–544.

Article  Google Scholar 

Sun MY, Bhaskar SMM. When two maladies meet: disease burden and pathophysiology of stroke in cancer. Int J Mol Sci. 2022;23:15769.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zaorsky NG, Zhang Y, Tchelebi LT, Mackley HB, Chinchilli VM, Zacharia BE. Stroke among cancer patients Nat Commun. 2019;10:5172.

PubMed  Google Scholar 

Jiang J, Shang X, Zhao J, Cao M, Wang J, Li R, et al. Score for predicting active cancer in patients with ischemic stroke: a retrospective study. Biomed Res Int. 2021;2021:5585206.

Article  PubMed  PubMed Central  Google Scholar 

Tybjerg AJ, Skyhøj Olsen T, Andersen KK. Prevalence and risk of occult cancer in stroke. Acta Neurol Scand. 2020;141:204–11.

Article  PubMed  Google Scholar 

Wilbers J, Sondag L, Mulder S, Siegerink B, van Dijk EJ. Cancer prevalence higher in stroke patients than in the general population: the Dutch String-of-Pearls Institute (PSI) Stroke study. Eur J Neurol. 2020;27:85–91.

Article  CAS  PubMed  Google Scholar 

Rioux B, Gioia LC, Keezer MR. Risk of cancer following an ischemic stroke in the Canadian longitudinal study on aging. Can J Neurol Sci. 2022;49:225–30.

Article  PubMed  Google Scholar 

Jacob L, Kostev K. Cancer risk in stroke survivors followed for up to 10 years in general practices in Germany. J Cancer Res Clin Oncol. 2019;145:1013–20.

Article  PubMed  Google Scholar 

Jiang S, Guo Y. Epigenetic clock: DNA methylation in aging. Stem Cells Int. 2020;2020:1047896.

Article  PubMed  PubMed Central  Google Scholar 

Ryan CP. “Epigenetic clocks”: theory and applications in human biology. Am J Hum Biol. 2021;33:1–18.

Article  Google Scholar 

Fransquet PD, Wrigglesworth J, Woods RL, Ernst ME, Ryan J. The epigenetic clock as a predictor of disease and mortality risk: a systematic review and meta-analysis. Clin Epigenetics. 2019;11:62.

Article  PubMed  PubMed Central  Google Scholar 

Zheng Y, Joyce BT, Colicino E, Liu L, Zhang W, Dai Q, et al. Blood epigenetic age may predict cancer incidence and mortality. EBioMedicine. 2016;5:68–73.

Article  PubMed  PubMed Central  Google Scholar 

Soriano-Tárraga C, Giralt-Steinhauer E, Mola-Caminal M, Vivanco-Hidalgo RM, Ois A, Rodríguez-Campello A, et al. Ischemic stroke patients are biologically older than their chronological age. Aging (Albany NY). 2016;8:2655.

Article  PubMed  Google Scholar 

Soriano-Tárraga C, Mola-Caminal M, Giralt-Steinhauer E, Ois A, Rodríguez-Campello A, Cuadrado-Godia E, et al. Biological age is better than chronological as predictor of 3-month outcome in ischemic stroke. Neurology. 2017;89:830–6.

Article  PubMed  Google Scholar 

Jiménez-Balado J, Giralt-Steinhauer E, Fernández-Pérez I, Rey L, Cuadrado-Godia E, Ois Á, et al. Epigenetic clock explains white matter hyperintensity burden irrespective of chronological age. Biology (Basel). 2023;12:33.

Google Scholar 

Macias-Gómez A, Jiménez-Balado J, Fernández-Pérez I, Suárez-Pérez A, Vallverdú-Prats M, Guimaraens L, et al. The influence of epigenetic biological age on key complications and outcomes in aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2024;95:675–81.

Article  PubMed  Google Scholar 

Fernández-Pérez I, Jiménez-Balado J, Lazcano U, Giralt-Steinhauer E, Rey Álvarez L, Cuadrado-Godia E, et al. Machine learning approximations to predict epigenetic age acceleration in stroke patients. Int J Mol Sci. 2023;24:2759.

Article  PubMed  PubMed Central  Google Scholar 

Van Swieten JC, Koudstaal PJ, Visser MC, Schouten H, Van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604–7.

Article  PubMed  Google Scholar 

Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, David, et al. Classification of subtype of acute ischemic stroke definitions for use in a multicenter clinical trial. Stroke. 1993;24:35–41.

Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD, et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014;30:1363–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fernández-Pérez I, Jiménez-Balado J, Macias-Gómez A, Suárez Pérez A, Vallverdú-Prats M, Pérez-Giraldo A, et al. Blood DNA methylation analysis reveals a distinctive epigenetic signature of vasospasm in aneurysmal subarachnoid hemorrhage. Transl Stroke Res. 2024. https://doi.org/10.1007/s12975-024-01252-x.

Jiménez-Balado J, Fernández-Pérez I, Gallego-Fábrega C, Lazcano U, Soriano-Tárraga C, Vallverdú-Prats M, et al. DNA methylation and stroke prognosis: an epigenome-wide association study. Clin Epigenetics. 2024;16:75.

Article  PubMed  PubMed Central  Google Scholar 

Labarre BA, Goncearenco A, Petrykowska HM, Jaratlerdsiri W, Bornman MSR, Hayes VM, et al. MethylToSNP: identifying SNPs in Illumina DNA methylation array data. Epigenetics Chromatin. 2019;12:79.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Teschendorff AE, Marabita F, Lechner M, Bartlett T, Tegner J, Gomez-Cabrero D, et al. A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data. Bioinformatics. 2013;29:189–96.

Article  CAS  PubMed  Google Scholar 

Hannum G, Guinney J, Zhao L, Zhang L, Hughes G, Sadda SV, et al. Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol Cell. 2013;49:359–67.

Article  CAS  PubMed  Google Scholar 

Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013;14:R115.

Article  PubMed  PubMed Central  Google Scholar 

Levine ME, Lu AT, Quach A, Chen BH, Assimes TL, Bandinelli S, et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging. 2018;10:573–91.

Article  PubMed  PubMed Central  Google Scholar 

Zhang Q, Vallerga CL, Walker RM, Lin T, Henders AK, Montgomery GW, et al. Improved precision of epigenetic clock estimates across tissues and its implication for biological ageing. Genome Med. 2019;11:54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang Z, Wong A, Kuh D, Paul DS, Rakyan VK, Leslie RD, et al. Correlation of an epigenetic mitotic clock with cancer risk. Genome Biol. 2016;17:1–8.

Article  CAS  Google Scholar 

Salas LA, Zhang Z, Koestler DC, Butler RA, Hansen HM, Molinaro AM, et al. Enhanced cell deconvolution of peripheral blood using DNA methylation for high-resolution immune profiling. Nat Commun. 2022;13:761.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luo Q, Dwaraka VB, Chen Q, Tong H, Zhu T, Seale K, et al. A meta-analysis of immune-cell fractions at high resolution reveals novel associations with common phenotypes and health outcomes. Genome Med. 2023;15:59.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng SC, Breeze CE, Beck S, Teschendorff AE. Identification of differentially methylated cell types in epigenome-wide association studies. Nat Methods. 2018;15:1059–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc: Ser B (Methodol). 1995;57:289–300.

Article  Google Scholar 

Stocks T, Van Hemelrijck M, Manjer J, Bjørge T, Ulmer H, Hallmans G, et al. Blood pressure and risk of cancer incidence and mortality in the metabolic syndrome and cancer project. Hypertension. 2012;59:802–10.

Article  CAS  PubM